Voriconazole for stubborn ringworm on the groin or trunk
Part of Infections, Skin clinical trials.
This study tests a medicine called voriconazole (an oral antifungal) for people whose ringworm infections on the groin or trunk have not responded to standard treatments. If you qualify, you would take this medicine to see if it can clear the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a stubborn tinea infection on your groin or trunk that did not clear up after 4 weeks of standard oral antifungal medicine (like terbinafine or itraconazole).
- The infection covers an area between 5 cm and 80 cm in total diameter.
- You are not allergic to azole medications (like fluconazole or itraconazole).
- You do not have a weakened immune system (for example, from cancer, tuberculosis, AIDS, organ transplant, or immune-suppressing drugs).
- You do not have diabetes, liver disease, or kidney disease.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two oral medications, fluconazole and itraconazole, to see which works better for treating ringworm that hasn't cleared up with topical creams. If you've had ringworm for at least 6 months despite using antifungal creams, this study may help find a more effective treatment.
This study tests if ultraviolet B (UVB) light therapy can help treat ringworm infections that have not cleared with standard antifungal pills. It may be an option if you have had multiple ringworm infections or one that keeps coming back.
This study tests a new type of injection treatment for stubborn ringworm (tinea) infections that haven't improved with standard pills or creams. It aims to see if this immunotherapy works better for hard-to-treat cases, especially when the fungus might be resistant to usual medicines.
This study compares two treatments for a common fungal skin infection called tinea (ringworm). One group gets itraconazole alone, the other gets itraconazole plus isotretinoin. The goal is to see which approach clears the infection faster, safer, and with a higher cure rate.
This study is looking at hard-to-treat fungal skin infections to see what they look like under a microscope and under special skin imaging (dermoscopy). It may help find better ways to treat these stubborn infections.
This trial tests if using genetic information can help doctors choose the right dose of the antifungal drug voriconazole. It aims to improve treatment and reduce side effects for people with fungal infections.
Hear when a new Dermatophyte Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.